Genomic Assays in Early Breast Cancer

Episode 74 · May 6th, 2021 · 1 hr 6 mins

About this Episode

Dr Kevin Kalinsky from Emory University in Atlanta discusses the role of genomic assays in treatment decision-making for patients with hormone receptor-positive, HER2-negative, early-stage breast cancer.

CME information and select publications here.